Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Tomo Hiromasa"'
Autor:
Hiroshi Mori, Hiroshi Wakabayashi, Shintaro Saito, Kenichi Nakajima, Kotaro Yoshida, Tomo Hiromasa, Seigo Kinuya
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-10 (2024)
Abstract This study aimed to compare tumor lesion detectability and diagnostic accuracy of whole-body magnetic resonance imaging (WB-MRI) and radioiodine-labeled meta-iodo-benzylguanidine (mIBG) imaging techniques in patients with metastatic pheochro
Externí odkaz:
https://doaj.org/article/8e206736e24f4c729807436ea7041ef2
Autor:
Zhuoqing Chen, Hiroshi Wakabayashi, Rie Kuroda, Hiroshi Mori, Tomo Hiromasa, Daiki Kayano, Seigo Kinuya
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-8 (2024)
Abstract DNA double-strand breaks (DSBs) are considered the most relevant lesions to the DNA damage of ionizing radiation (IR), and γ-H2AX foci in peripheral blood lymphocytes are regarded as an adequate marker for DSB quantitative studies. This stu
Externí odkaz:
https://doaj.org/article/80a8530afa3249d1adaf09e927dd7bbd
Autor:
Hiroshi Mori, Hiroshi Wakabayashi, Shintaro Saito, Kenichi Nakajima, Kotaro Yoshida, Tomo Hiromasa, Seigo Kinuya
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-1 (2024)
Externí odkaz:
https://doaj.org/article/cd9fbe83ae7a4c8da1fc5309ca1161d5
Autor:
Hiroshi Wakabayashi, Takahiro Konishi, Hiroto Yoneyama, Anri Inaki, Tomo Hiromasa, Takafumi Yamase, Norihito Akatani, Satoru Watanabe, Hiroshi Mori, Daiki Kayano, Seigo Kinuya
Publikováno v:
Asia Oceania Journal of Nuclear Medicine and Biology, Vol 7, Iss 2, Pp 115-120 (2019)
Objective(s): Single-photon emission computed tomography (SPECT) using metaiodobenzylguanidine (MIBG) is an important diagnostic tool for the treatment of refractory pheochromocytoma and paraganglioma (PPGL). Owing to the difficulty of SPECT quantifi
Externí odkaz:
https://doaj.org/article/3c09b522caea46bdb6bf3e48c967f815
Autor:
Hiroshi Wakabayashi, Daiki Kayano, Anri Inaki, Raita Araki, Rie Kuroda, Norihito Akatani, Takafumi Yamase, Satoru Watanabe, Tomo Hiromasa, Yuji Kunita, Hiroshi Mori, Shintaro Saito, Yasuhiro Ikawa, Toshihiro Fujiki, Seigo Kinuya
Publikováno v:
Diagnostics, Vol 10, Iss 9, p 663 (2020)
123I-meta-iodobenzylguanidine (123I-mIBG) scintigraphy is used for evaluating disease extent in children with neuroblastoma. 131I-mIBG therapy has been used for evaluation in children with high-risk neuroblastoma, and post-therapy 131I-mIBG scintigra
Externí odkaz:
https://doaj.org/article/66f78a23b1f946638aa7f886539e7062
Autor:
Hiroshi Wakabayashi, Hiroshi Mori, Tomo Hiromasa, Norihito Akatani, Anri Inaki, Takashi Kozaka, Yoji Kitamura, Kazuma Ogawa, Seigo Kinuya, Junichi Taki
Publikováno v:
Journal of Nuclear Cardiology. 30:653-661
Autor:
Takayuki Kanno, Masahisa Onoguchi, Takayuki Shibutani, Tomo Hiromasa, Hiroshi Wakabayashi, Seigo Kinuya
Objective: In the field of small animal imaging, Versatile emission computed tomography/computed tomography (VECTor/CT) allows for fully simultaneous acquisition with SPECT and PET tracer using a clustered multi-pinhole collimator. We determined opti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::72f186377e9a3b2d17a0a88f4533431c
https://doi.org/10.21203/rs.3.rs-2706802/v1
https://doi.org/10.21203/rs.3.rs-2706802/v1
Publikováno v:
Seminars in Nuclear Medicine.
Autor:
Norihito Akatani, Hiroshi Wakabayashi, Daiki Kayano, Anri Inaki, Aki Takata, Tomo Hiromasa, Takafumi Yamase, Yuji Kunita, Satoru Watanabe, Hiroshi Mori, Shintaro Saito, Kenichi Nakajima, Seigo Kinuya
Publikováno v:
Endocrine journal.
Long-term survival in patients with differentiated thyroid cancer (DTC) and lung metastasis remains unexplored in Japan. This study aimed to investigate the long-term survival and prognostic factors of radioiodine therapy (RIT) in a University Hospit
Autor:
Anri Inaki, Tohru Shiga, Yoshito Tsushima, Megumi Jinguji, Hiroshi Wakabayashi, Daiki Kayano, Norihito Akatani, Takafumi Yamase, Yuji Kunita, Satoru Watanabe, Tomo Hiromasa, Hiroshi Mori, Kenji Hirata, Shiro Watanabe, Tetsuya Higuchi, Hiroyasu Tomonaga, Seigo Kinuya
Publikováno v:
Annals of Nuclear Medicine. 36:267-278
Objective In this phase II study, we aimed to investigate the efficacy and safety of single-dose [131I]meta-iodobenzylguanidine (131I-mIBG) therapy in patients with refractory pheochromocytoma and paraganglioma (PPGL). Patients and methods This study